| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/03/1993 | CA2083778A1 Variable region within fibroblast growth factor receptors that confers ligand specificity |
| 06/02/1993 | EP0544467A2 Plasmid pHKY334, an expression vector for EK-BGH and host cells transformed therewith |
| 06/02/1993 | EP0544466A1 Tri-arginine insulins |
| 06/02/1993 | EP0544293A2 Process for the preparation of biologically active NGF by genetic engineering |
| 06/02/1993 | CN1072723A Tri-arginine insulins. |
| 06/02/1993 | CN1072687A Anti-alphab-integrin antibodies |
| 06/01/1993 | US5216133 Thermosensitive, trypsin, chymotrypsin and mercaptam sensitive, pure protein |
| 06/01/1993 | US5216132 Soluble t-cell antigen receptor chimeric antigens |
| 06/01/1993 | US5216128 IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it |
| 06/01/1993 | US5215913 IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use |
| 06/01/1993 | US5215895 Dna encoding a mammalian cytokine, interleukin-11 |
| 06/01/1993 | US5215892 C/EBP2 gene and recombinant C/EBP2 |
| 06/01/1993 | US5215889 Catalytic and reactive polypeptides and methods for their preparation and use |
| 06/01/1993 | US5215790 Treating interstitial surface with first agent, exposing to oxidizing gas to remove exterior, treating with second agent |
| 06/01/1993 | CA1318630C Preparation of antibiotic chloropolysporin c |
| 06/01/1993 | CA1318626C Method for preparative expression of genes in cell-free system of conjugated transcription/translation |
| 06/01/1993 | CA1318622C Heteropolysaccharide s-184 |
| 06/01/1993 | CA1318621C Heteropolysaccharide s-657 |
| 06/01/1993 | CA1318619C Method of using eukaryotic expression vectors comprising the bk virus enhancer |
| 06/01/1993 | CA1318617C Enhanced secretion of heterologous proteins by hosts using substituted promoters |
| 06/01/1993 | CA1318616C Repressible yeast promoters |
| 05/28/1993 | CA2083529A1 Plasmid phky334, an expression vector for ek-bgh and host cells transformed therewith |
| 05/27/1993 | WO1993010249A1 A bacillus promoter derived from a variant of a bacillus licheniformis x-amylase promoter |
| 05/27/1993 | WO1993010242A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 05/27/1993 | WO1993010237A1 Recombinant vaccine against lyme disease |
| 05/27/1993 | WO1993010236A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | WO1993010235A1 Human il-4 mutant proteins |
| 05/27/1993 | WO1993010233A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
| 05/27/1993 | WO1993010232A1 Lymphoid cd30-antigen |
| 05/27/1993 | WO1993010231A1 Collagen-like polypeptides |
| 05/27/1993 | WO1993010229A1 Fusion proteins comprising mgf and il-3 |
| 05/27/1993 | WO1993010221A1 Chimeric murine/human anti-idiotype monoclonal antibodies |
| 05/27/1993 | WO1993010220A1 Soluble mhc molecules and their uses |
| 05/27/1993 | WO1993010154A1 High molecular weight collagen-like protein polymers |
| 05/27/1993 | WO1993010152A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
| 05/27/1993 | WO1993010151A1 Receptor for oncostatin m and leukemia inhibitory factor |
| 05/27/1993 | WO1993010150A1 Expression of neurotrophic factors with heterologous prepro regions |
| 05/27/1993 | WO1993010134A1 Ganglioside analogs |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009808A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R |
| 05/27/1993 | WO1993004172A3 Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula |
| 05/27/1993 | DE4209110A1 Neue thrombininhibitorische proteine aus landblutegeln Country leeches novel thrombin proteins from |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2123874A1 Methods for detecting and isolating upa-r and inhibiting the binding of upa to upa-r |
| 05/27/1993 | CA2123316A1 High molecular weight collagen-like protein polymers |
| 05/27/1993 | CA2123234A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
| 05/27/1993 | CA2123213A1 Ganglioside analogs |
| 05/27/1993 | CA2123210A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | CA2123121A1 Recombinant vaccine against lyme disease |
| 05/27/1993 | CA2083360A1 Tri-arginine insulins |
| 05/26/1993 | EP0543195A2 Biosynthetic process for the preparation of proteins |
| 05/26/1993 | EP0543091A2 Monoclonal antibody reacting with Pseudomonas aeruginosa |
| 05/26/1993 | EP0542998A1 Vaccine and treatment method of human immunodeficiency virus infection |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0542970A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
| 05/26/1993 | EP0542949A1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines |
| 05/26/1993 | EP0542931A1 Serine protease variants having peptide ligase activity |
| 05/26/1993 | EP0542929A1 Glycogen biosynthetic enzymes in plants |
| 05/26/1993 | EP0542920A1 Cannabinoid receptor |
| 05/26/1993 | EP0542897A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors. |
| 05/26/1993 | EP0542892A1 Chimeric neurotrophic factors |
| 05/26/1993 | EP0542863A1 Expression of recombinant polypeptides with improved purification |
| 05/26/1993 | EP0542833A1 Insecticidal proteins |
| 05/26/1993 | EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 05/26/1993 | EP0527802A4 Ligand for the neu gene product |
| 05/26/1993 | EP0167575B1 Cardiodilatine, a new peptide hormone and production process thereof |
| 05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
| 05/26/1993 | CN1020857C Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses |
| 05/25/1993 | US5213980 Fibroblast growth factor gene transformed hybridoma and enhanced production of antibody |
| 05/25/1993 | US5213971 Process for inducing cytochrome P-450 enzymes in Streptomyces bacteria and determining the mutagenicity of chemicals |
| 05/25/1993 | US5213962 Purification, detection and methods of use of protease Nexin-2 |
| 05/25/1993 | CA1318271C Expression control sequence |
| 05/19/1993 | EP0542679A1 Novel hybrid transforming growth factors |
| 05/19/1993 | EP0542466A2 Baculovirus transfer vectors |
| 05/19/1993 | EP0542424A1 Oxytocin recepto and DNA coding for the same |
| 05/19/1993 | EP0542287A2 Anti-human ornithine decarboxylase antibody |
| 05/19/1993 | EP0542255A1 Monoclonal antibody recognizing the C-terminus of hBNP |
| 05/19/1993 | EP0541753A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT. |
| 05/19/1993 | EP0541726A1 Growth factor compositions, preparation and use |
| 05/19/1993 | EP0541721A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 05/19/1993 | EP0541692A1 Herpes simplex virus vp16 vaccines |
| 05/19/1993 | EP0541691A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 05/19/1993 | EP0541645A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 05/19/1993 | EP0541629A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 05/19/1993 | EP0343186B1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY $i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM |
| 05/19/1993 | DE4137333A1 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung Therapeutic agents which are antagonists or partial agonists of human interleukin 4 are or contain hIL-4 mutant proteins as well as for their preparation vefahren |
| 05/19/1993 | CN1020733C Process for preparing covalent conjunct agent of bacterial polysaccharide and immunogen protein |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212091 Method of producing tissue factor pathway inhibitor |
| 05/18/1993 | US5212087 Plasmids |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5212074 Genetic material encoding new insulin-like growth factor binding protein igfbp-6 |
| 05/18/1993 | US5212072 Genetic engineering and DNA sequences |
| 05/18/1993 | US5212058 Nucleic acid encoding ubiquitin-specific proteases |
| 05/18/1993 | US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/18/1993 | CA1317880C Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
| 05/13/1993 | WO1993009235A2 Ubiquitin-specific proteases |
| 05/13/1993 | WO1993009234A2 Suppressor and progenitor cells |
| 05/13/1993 | WO1993009232A1 NOVEL THROMBIN INHIBITOR PROTEIN FROM $i(REDUVII) |
| 05/13/1993 | WO1993009231A1 Novel thrombin-inhibiting protein from ticks |